ASN's Mission

To create a world without kidney diseases, the ASN Alliance for Kidney Health elevates care by educating and informing, driving breakthroughs and innovation, and advocating for policies that create transformative changes in kidney medicine throughout the world.

learn more

Contact ASN

1401 H St, NW, Ste 900, Washington, DC 20005

email@asn-online.org

202-640-4660

The Latest on Twitter

Kidney Week

Abstract: TH-PO298

The Symptom Profile of Hemodialysis Patients in Ontario

Session Information

Category: Dialysis

  • 701 Dialysis: Hemodialysis and Frequent Dialysis

Authors

  • Glazer, Alysha, Ontario Renal Network, Toronto, Ontario, Canada
  • Mackinnon, Marnie, Ontario Renal Network, Toronto, Ontario, Canada
  • Heale, Esti, Ontario Renal Network, Toronto, Ontario, Canada
  • Moolji, Carey, Ontario Renal Network, Toronto, Ontario, Canada
  • Ip, Jane, Cancer Care Ontario, Toronto, Ontario, Canada
  • Na, Yingbo, Cancer Care Ontario, Toronto, Ontario, Canada
  • Xu, Yanqing, Bristol-Myers Squibb, Lawrenceville, New Jersey, United States
  • Blake, Peter G., London Health Sciences Centre, London, Ontario, Canada
  • Walsh, Michael, McMaster University, Hamilton, Ontario, Canada
Background

People requiring dialysis reportedly experience a high symptom burden. However, there are few large studies assessing symptoms of this patient population over time. The Ontario Renal Network (ORN) is pilot testing a standardized provincial approach to symptom screening, assessment, and management using the Edmonton Symptom Assessment System Revised: Renal (ESAS-r:Renal).

Methods

Eight Regional Renal Programs in Ontario were selected to participate in a one year pilot project. Participating programs routinely assess patients undergoing in-facility hemodialysis with ESAS-r:Renal every 4 to 6 weeks. The ESAS-r:Renal questionnaire asks patients to self-report the severity of 12 symptoms between 0 (no symptom) and 10 (worst possible symptom).

Results

Between April 1 and December 31, 2017, there were 5,839 screening attempts by 1,267 patients with 90% of the questionnaires fully completed and 5% partially completed. Forty-two percent of patients were female, 48% had diabetes (Type 1 or 2), and 32% were on dialysis for 5 or more years.
Patients frequently reported changes in symptom scores over time. Tiredness was the most common symptom reported (76% of all surveys) and nausea the least reported (26% of all surveys). Scores of 7 or greater were recorded frequently (pain [14%], tiredness [22%], drowsiness [12%], nausea [3%], poor appetite [7%], shortness of breath [6%], depression [7%], anxiety [6%], poor wellbeing [11%], itching [12%], problems sleeping [17%], and restless legs [13%]).

Conclusion

Patients receiving in-facility dialysis frequently have symptoms. The degree to which the symptoms reported through ESAS-r:Renal can be modified and improved requires further research.

Funding

  • Government Support - Non-U.S.